Lacey David L.
SEC insider (Form 3/4/5 filer). CIK 0001734422. Director at Arcus Biosciences, Inc. (RCUS) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in HAYWARD, CA.
Companies Lacey David L. has filed insider reports for
- Arcus Biosciences, Inc. (RCUS): Director
- Nurix Therapeutics, Inc. (NRIX): Director
Lacey David L.
CIK: 0001734422
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 11, 2026RCUS
Arcus Biosciences, Inc.
AwardDirect5.7K shares- - May 15, 2026NRIX
Nurix Therapeutics, Inc.
AwardDirectDirector Stock Option (right to buy)
31.3K shares- - Jun 10, 2025RCUS
Arcus Biosciences, Inc.
AwardDirect13.3K shares- - May 19, 2025NRIX
Nurix Therapeutics, Inc.
AwardDirectDirector Stock Option (right to buy)
25K shares- - Jan 23, 2025RCUS
Arcus Biosciences, Inc.
AwardDirectStock Option (right to buy)
5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  RCUS Arcus Biosciences, Inc. | Award | 5,700 | - | $0 | Direct |
| May 15, 2026 |  NRIX Nurix Therapeutics, Inc. | Award Director Stock Option (right to buy) | 31,250 | - | - | Direct |
| Jun 10, 2025 | RCUS Arcus Biosciences, Inc. | Award | 13,300 | - | - | Direct |
| May 19, 2025 | NRIX Nurix Therapeutics, Inc. | Award Director Stock Option (right to buy) | 25,000 | - | - | Direct |
| Jan 23, 2025 | RCUS Arcus Biosciences, Inc. | Award Stock Option (right to buy) | 5,000 | - | - | Direct |
1-5 of 5 transactions